Healthcare Services

Neurological Disorder Diagnostics Market Revenue Expected to Reach $17.74 Billion by 2030 with 7% CAGR

April 3, 2026April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Neurological Disorder Diagnostics Market By 2030 Starting From Its 2026 Size?

The neurological disorder diagnostics market has experienced significant growth in recent years. This market is set to expand from $12.61 billion in 2025 to $13.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. Historically, this expansion has been propelled by factors such as the increasing prevalence of neurological disorders, a growing understanding of the importance of early diagnosis, the development of advanced imaging infrastructure, rising research funding for neurology, and enhanced availability of diagnostic instruments.

The neurological disorder diagnostics market is projected to experience substantial expansion in the coming years, reaching $17.75 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.0%. This anticipated growth during the forecast period can be linked to factors such as the increasing integration of precision neurology approaches, greater investments in digital diagnostics platforms, the broadening of personalized treatment planning, the expanding utilization of tele-neurology services, and progress in neuroinformatics and analytics. Key trends during this period are expected to encompass a wider uptake of AI-assisted neuroimaging tools, an increase in the deployment of biomarker-based diagnostic kits, greater integration of genetic and molecular testing, the spread of remote and digital cognitive assessments, and a heightened emphasis on early disease detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19611&type=smp

What Primary Drivers Are Shaping The Development Of The Neurological Disorder Diagnostics Market?

The rising occurrence of Alzheimer’s disease is projected to drive the expansion of the neurological disorder diagnostics market in the future. Alzheimer’s disease is defined as a progressive neurodegenerative condition marked by a slow deterioration of cognitive abilities, such as memory, reasoning, and problem-solving. Its development is linked to a combination of genetic factors, including specific gene mutations and variations, the buildup of amyloid plaques and tau tangles within the brain, persistent inflammation, vascular problems, and various lifestyle elements. Neurological disorder diagnostics aid in addressing Alzheimer’s disease by facilitating its early and precise identification via sophisticated imaging methods, biomarker analysis, and cognitive evaluations. For example, in September 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that in 2023, approximately 411,100 individuals in Australia were living with dementia, encompassing around 257,500 women and 153,700 men. Consequently, the growing prevalence of Alzheimer’s disease is fueling the expansion of the neurological disorder diagnostics market.

Which Segment Categories Define The Neurological Disorder Diagnostics Market?

The neurological disorder diagnostics market covered in this report is segmented –

1) By Component: Instruments, Reagents, Kits, Software, Services

2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques

3) By Disease Type: Alzheimer’s Disease, Dementia, Parkinson’s Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types

4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

Subsegments:

1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices,

2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents

3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders

4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software

5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services

How Are Trends Transforming The Neurological Disorder Diagnostics Market Landscape?

Companies operating within the neurological disorder diagnostics market are prioritizing the development of innovative solutions, such as neurological disease quantification software, to address the needs of one billion individuals worldwide affected by neurological diseases. Neurological disease quantification software functions as a tool for measuring and analyzing brain activity and the progression of neurological conditions. For example, in January 2024, Quibim, a Spain-based biotechnology company, launched the QP-Brain, an AI-based early-stage neurological disease quantification software. QP-Brain by Quibim is advanced neuroimaging analysis software crafted to quantify brain tissue alterations associated with neurological diseases. Its distinctive features encompass AI-powered automated segmentation and detailed volumetric analysis, delivering precise insights into brain structure changes for both clinical and research applications.

Who Are The Top Companies Competing In The Neurological Disorder Diagnostics Market?

Major companies operating in the neurological disorder diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co.Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation

Read the full neurological disorder diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/neurological-disorder-diagnostics-global-market-report

How Does The Neurological Disorder Diagnostics Market Perform Across Major Global Regions?

North America was the largest region in the neurological disorder diagnostics market in 2025. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Neurological Disorder Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19611&type=smp

Browse Through More Reports Similar to the Global Neurological Disorder Diagnostics Market 2026, By The Business Research Company

Central Nervous System Biomarkers Global Market Report

https://www.thebusinessresearchcompany.com/report/central-nervous-system-biomarkers-global-market-report

Clinical Biomarkers Global Market Report

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Biomarkers Global Market Report

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795